Uromitexan is named as an intervention in 2 current clinical trials in our Germany, Canada, Australia and Israel registers. 2 are recruiting patients now. The most common phase is Phase 1/2. The sponsor with the most trials is CuraCell TX AB (1). The most-studied condition is Metastatic Colorectal Cancer.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT
NCT04684368 · ClinicalTrials.gov ↗ · Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma, Embryonal Carcinoma
|
Phase 2 | Recruiting | Children's Oncology Group | Canada, Australia, Israel |
|
A FIH, Phase I/IIa, Trial Assessing Feasibility of Administrations of TIL-based Immunotherapy in Patients With Metastatic CRC and PC
NCT07255664 · ClinicalTrials.gov ↗ · Metastatic Colorectal Cancer, Prostate Cancer Metastatic, Prostate Cancer Locally Advanced
|
Phase 1/2 | Recruiting | CuraCell TX AB | Germany |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| CuraCell TX AB | 1 |
| Children's Oncology Group | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Germany | 1 | 1 |
| Clinical trials in Canada | 1 | 1 |
| Clinical trials in Australia | 1 | 1 |
| Clinical trials in Israel | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our Germany, Canada, Australia and Israel registers name Uromitexan as a drug or biological intervention, as of the registry sync on 1 October 2026. Completed and withdrawn studies are not counted.
Yes. 2 of the 2 trials are recruiting: 1 with sites in Germany, 1 with sites in Canada, 1 with sites in Australia and 1 with sites in Israel. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
CuraCell TX AB (1) and Children's Oncology Group (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Uromitexan works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Uromitexan works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Uromitexan (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 1 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.